Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6.

Authors

D P Chew¹, D L Bhatt, M A Robbins, D Mukherjee, M Roffi, J P Schneider, E J Topol, S G Ellis

Affiliation

¹ Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

PMID: 11564394
DOI: 10.1016/s0002-9149(01)01813-6

No abstract available

MeSH terms

Aged
Angioplasty, Balloon, Coronary*
Aspirin / administration & dosage
Aspirin / therapeutic use*
C-Reactive Protein / metabolism*
Clopidogrel
Female
Humans
Male
Myocardial Infarction / blood
Myocardial Infarction / mortality
Myocardial Infarction / therapy*
Ohio
Platelet Aggregation Inhibitors / administration & dosage
Platelet Aggregation Inhibitors / therapeutic use*
Premedication
Registries
Stents
Survival Analysis
Ticlopidine / administration & dosage
Ticlopidine / analogs & derivatives
Ticlopidine / therapeutic use*
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
C-Reactive Protein
Clopidogrel
Ticlopidine
Aspirin